| Date Filed | Type | Description |
| 08/17/2023 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 217,770 shares
@ $0
Granted 42,345 options to buy
@ $1.2, valued at
$50.8k
|
|
| 11/17/2022 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Granted 144,639 shares
@ $0 |
|
| 10/11/2022 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Xtant Medical Holdings, Inc.|
Txns:
| Bought 2,264,861 shares
@ $0.48, valued at
$1.1M
Bought 566,214 options to buy
@ $0.48, valued at
$271.8k
|
|
| 09/06/2022 |
SC 13D
| Vizirgianakis Stavros G. reports a 6.6% stake in Xtant Medical Holdings, Inc. |
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2022 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Bioventus Inc.|
Txns:
| Exercised 965 restricted stock units
@ $0
Granted 16,648 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Bioventus Inc.|
Txns:
| Granted 2,780,923 shares
@ $0 |
|
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
4
| Vizirgianakis Stavros G. (Director) has filed a Form 4 on Bioventus Inc.|
Txns:
| Granted 26,179 options to buy
@ $7.57, valued at
$198.2k
Granted 6,544 options to buy
@ $3.33, valued at
$21.8k
Granted 19,634 options to buy
@ $4.13, valued at
$81.1k
Granted 34,905 options to buy
@ $12.27, valued at
$428.3k
Granted 347,323 options to buy
@ $5.63, valued at
$2M
Granted 89,001 options to buy
@ $7.78, valued at
$692.4k
Granted 261,794 options to buy
@ $12.71, valued at
$3.3M
Granted 2,895 restricted stock units
@ $0 |
|
| 11/02/2021 |
3
| Vizirgianakis Stavros G. (Director) has filed a Form 3 on Bioventus Inc. |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Vizirgianakis Stavros G. (CEO) has filed a Form 4 on MISONIX INC|
Txns:
| Granted 199,005 options
@ $9.82, valued at
$2M
|
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Vizirgianakis Stavros G. (President and CEO) has filed a Form 4 on MISONIX INC|
Txns:
| Granted 20,000 options
@ $21.41, valued at
$428.2k
|
|
| 09/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/26/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2013 |
3
| Vizirgianakis Stavros G. (Director) has filed a Form 3 on MISONIX INC |
| 05/10/2013 |
SC 13D/A
| Vizirgianakis Stavros G. reports a 5.4% stake in MISONIX, INC. |
| 10/12/2012 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |